| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 40,000 | $6.04 | $241,550.00 | -2.0% | |
| Sep 15, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 13,100 | $5.82 | $76,242.00 | -1.9% | |
| Sep 14, 2015 | NOTV Inotiv, Inc. | Downing Philip A | VP, Preclinical Srvcs. | Buy | 3,000 | $1.73 | $5,190.00 | +75.0% | |
| Sep 14, 2015 | RVTY Revvity, Inc. | Corbett James | Please See Remarks | Sell | 3,000 | $47.59 | $142,776.00 | -12.2% | |
| Sep 14, 2015 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 14,562 | $39.41 | $573,888.42 | -22.1% | |
| Sep 14, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 15,204 | $5.76 | $87,575.04 | -2.2% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Stark James R | VP, Corporate Controller | Sell | 152 | $139.11 | $21,144.72 | -23.5% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 492 | $139.11 | $68,442.12 | -4.3% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 270 | $139.11 | $37,559.70 | -8.4% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Hall Shannon | Executive Vice President | Sell | 182 | $139.11 | $25,318.02 | -9.8% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Magni Giovanni | EVP, Chief Strategy Officer | Sell | 182 | $139.11 | $25,318.02 | -1.4% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Hutton Ronald W | Vice President And Treasurer | Sell | 111 | $139.11 | $15,441.21 | -4.5% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Schwartz Norman D | Chairman, President, And CEO | Sell | 3,809 | $138.18 | $526,341.13 | -0.3% | |
| Sep 14, 2015 | PMDI Psychemedics Corp | Kubacki Raymond C Jr | Chairman, CEO &President | Buy | 2,000 | $10.12 | $20,245.00 | +0.5% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | Tsingos Christine A | EVP And CFO | Sell | 289 | $138.26 | $39,958.07 | -3.1% | |
| Sep 11, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 1,400 | $5.87 | $8,218.00 | -0.2% | |
| Sep 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Hall Shannon | Executive Vice President | Sell | 92 | $137.50 | $12,650.00 | -6.3% | |
| Sep 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Stark James R | VP, Corporate Controller | Sell | 76 | $137.50 | $10,450.00 | -23.5% | |
| Sep 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Hertia John | Executive Vice President | Sell | 228 | $137.50 | $31,350.00 | -2.2% | |
| Sep 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Hutton Ronald W | Vice President And Treasurer | Sell | 58 | $137.50 | $7,975.00 | -2.6% | |
| Sep 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Magni Giovanni | EVP, Chief Strategy Officer | Sell | 152 | $137.50 | $20,900.00 | -1.2% | |
| Sep 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 152 | $137.50 | $20,900.00 | -5.7% | |
| Sep 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Soderberg Shawn Marie55 | EVP, General Counsel, Sec | Sell | 152 | $137.50 | $20,900.00 | -24.2% | |
| Sep 10, 2015 | PMDI Psychemedics Corp | Lerner Neil | VP - Finance | Buy | 3,000 | $10.32 | $30,960.00 | +11.1% | |
| Sep 10, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 10,000 | $5.86 | $58,600.00 | -1.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.